Published in Thromb Res on April 02, 2008
Morphology and Progression in Primary Varicose Vein Disorder Due to 677C>T and 1298A>C Variants of MTHFR. EBioMedicine (2015) 0.82
Risk marker associations with venous thrombotic events: a cross-sectional analysis. BMJ Open (2014) 0.80
MTHFR polymorphisms in primary varicose vein disorder. EBioMedicine (2015) 0.75
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med (2012) 5.87
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology (2012) 3.04
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology (2015) 2.81
POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg (2009) 2.28
Asymptomatic carotid lesions and aging: Role of hypertension and other traditional and emerging risk factors. Arch Med Res (2006) 2.03
Ventricular tachycardia in non-compaction of left ventricle: is this a frequent complication? Pacing Clin Electrophysiol (2007) 1.78
Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting. Ann Thorac Surg (2010) 1.77
Chronic pharmacological treatment in takotsubo cardiomyopathy. Int J Cardiol (2007) 1.73
Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype. Am J Hematol (2010) 1.62
Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med (Hagerstown) (2014) 1.50
IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. J Hepatol (2012) 1.48
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma. Cancer Treat Rev (2010) 1.45
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. Menopause (2008) 1.44
An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb (2009) 1.44
Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs. Leuk Lymphoma (2014) 1.41
Asymptomatic ventricular pre-excitation in children. J Cardiovasc Med (Hagerstown) (2009) 1.39
Neuromuscular disorders and non compaction: how much is the strength of the association and how can it be suspected? Int J Cardiol (2008) 1.39
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J Med Chem (2003) 1.35
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch Intern Med (2010) 1.27
Rupture of a left sinus of Valsalva aneurysm into the pulmonary artery. Eur J Echocardiogr (2006) 1.25
Segmental dyskinesia in Wolff-Parkinson-White syndrome: a possible cause of dilatative cardiomyopathy. Int J Cardiol (2007) 1.18
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol (2005) 1.13
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. Blood (2005) 1.13
Non-coronary atherosclerosis. Eur Heart J (2014) 1.11
Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines. J Med Chem (2005) 1.10
[Coronary artery ectasia: etiopathogenesis, diagnosis and treatment]. G Ital Cardiol (Rome) (2014) 1.10
Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. Thromb Haemost (2009) 1.07
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke (2005) 1.06
Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr (2007) 1.05
Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. J Med Chem (2007) 1.04
The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS. Br J Clin Pharmacol (2008) 1.01
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther (2012) 1.01
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Haematologica (2011) 1.00
Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction. Transl Res (2011) 1.00
Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg (2008) 1.00
Task force on: 'Early markers of atherosclerosis: influence of age and sex'. J Cardiovasc Med (Hagerstown) (2013) 0.98
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells. Cancer Lett (2008) 0.97
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides. Eur J Med Chem (2008) 0.97
Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope. Open Cardiovasc Med J (2010) 0.95
Anticoagulant drugs in noncompaction: a mandatory therapy? J Cardiovasc Med (Hagerstown) (2008) 0.95
Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure. J Cardiovasc Pharmacol Ther (2010) 0.94
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. Transfusion (2010) 0.94
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis (2008) 0.94
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab (2013) 0.93
Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res (2006) 0.93
Design, synthesis, and biological evaluation of thiophene analogues of chalcones. Bioorg Med Chem (2008) 0.93
Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized. Intern Med (2011) 0.92
Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations. Eur J Haematol (2009) 0.92
Off-pump versus on-pump myocardial revascularization in patients with ST-segment elevation myocardial infarction: a randomized trial. J Thorac Cardiovasc Surg (2009) 0.92
Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. Arch Med Res (2007) 0.92
Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides. Eur J Med Chem (2011) 0.91
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Am J Hematol (2012) 0.89
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors. J Med Chem (2006) 0.89
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease. PLoS One (2013) 0.88
Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years. Mayo Clin Proc (2009) 0.88
Papillary muscle relocation in conjunction with valve annuloplasty improve repair results in severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2011) 0.88
Magnetic resonance in isolated noncompaction of the ventricular myocardium. Int J Cardiol (2008) 0.87
Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers. J Hypertens (2012) 0.87
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis. Dig Liver Dis (2011) 0.86
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization. Bioorg Med Chem (2009) 0.86
Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors. J Med Chem (2008) 0.86
Effects of ambient temperature, humidity, and other meteorological variables on hospital admissions for angina pectoris. Eur J Prev Cardiol (2011) 0.86
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C. Clin Gastroenterol Hepatol (2012) 0.85
Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathway. Int Immunopharmacol (2003) 0.85
Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. Bioorg Med Chem Lett (2006) 0.85
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. Blood Transfus (2012) 0.84
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity. Eur J Med Chem (2010) 0.84
Atherosclerosis, inflammation and Chlamydia pneumoniae. World J Cardiol (2009) 0.84
The PFO anatomy evaluation as possible tool to stratify the associated risks and the benefits arising from the closure. Eur J Echocardiogr (2010) 0.84
Antiproliferative agents that interfere with the cell cycle at the G1-->S transition: further development and characterization of a small library of stilbene-derived compounds. ChemMedChem (2008) 0.84
Atherosclerosis, degenerative aortic stenosis and statins. Curr Drug Targets (2011) 0.84
Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms. Ann Hematol (2009) 0.84
EGFR genomic alterations in cancer: prognostic and predictive values. Front Biosci (Elite Ed) (2011) 0.84
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. Stroke (2005) 0.84
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization. Bioorg Med Chem (2008) 0.84
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. Transfus Med (2011) 0.84
Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Cardiol (2006) 0.83
High dose of trimethoprim-sulfamethoxazole and daptomycin as a therapeutic option for MRSA endocarditis with large vegetation complicated by embolic stroke: a case report and literature review. Infez Med (2013) 0.83
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER. Br J Haematol (2010) 0.83
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. Coron Artery Dis (2009) 0.83
Carotid artery intima-media thickness: normal and percentile values in the Italian population (camp study). Eur J Cardiovasc Prev Rehabil (2011) 0.83
Helicobacter pylori and atrial fibrillation: absence of correlations. J Cardiovasc Med (Hagerstown) (2009) 0.83
Peripheral artery disease: potential role of ACE-inhibitor therapy. Vasc Health Risk Manag (2008) 0.83
The noncompaction of the left ventricular myocardium: our paediatric experience. J Cardiovasc Med (Hagerstown) (2007) 0.83
ICD implantation in noncompaction of the left ventricular myocardium: a case report. Pacing Clin Electrophysiol (2009) 0.83
Unusual case of left ventricular pseudoaneurysm. Circ J (2008) 0.83
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors. Eur J Med Chem (2011) 0.82
Methylenetetrahydrofolate reductase mutation in subjects with abdominal aortic aneurysm subdivided for age. Clin Hemorheol Microcirc (2006) 0.82